marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Relay Therapeutics Financial Ratios 2011-2024 | RLAY
Annual Financial Ratios Relay Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.8 | -6.7 | -8.0 | -33.8 | - | - | - | - | - | - | - | - | - |
P/S |
51.2 | 1407.6 | 964.6 | 21.4 | - | - | - | - | - | - | - | - | - |
EPS |
-2.8 | -2.6 | -3.8 | -5.4 | -21.8 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
1.26 B | 1.94 B | 2.75 B | 1.36 B | 532 M | 117 M | - | - | - | - | - | - | - |
EBITDA per Share |
-3 | -2.63 | -3.79 | -1.23 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-7.4 | -59.0 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | -2.22 | - | - | - | - | - | - | - | - | - | ||
P/B |
1.7 | 2.0 | 3.3 | 2.3 | - | - | - | - | - | - | - | - | - |
P/CF |
-4.4 | -8.5 | -39.3 | -17.3 | - | - | - | - | - | - | - | - | - |
ROE % |
-45.47 | -30.57 | -40.53 | -6.87 | - | - | - | - | - | - | - | - | - |
ROA % |
-40.52 | -26.42 | -36.08 | -6.55 | - | - | - | - | - | - | - | - | - |
ROCE % |
-49.60 | -31.50 | -40.62 | -7.31 | - | - | - | - | - | - | - | - | - |
Current Ratio |
9.2 | 7.4 | 9.1 | 21.9 | - | - | - | - | - | - | - | - | - |
DSO |
- | 93.7 | 4543.1 | 165.6 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 93.7 | 4543.1 | 165.6 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 93.7 | 4543.1 | 165.6 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Relay Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.63 | -0.69 | -0.62 | - | -0.54 | -0.81 | -0.78 | - | -0.76 | -0.71 | -0.57 | - | -0.66 | -2.1 | -0.47 | - | -3 | -6.06 | -5.99 | - | -5.53 | -5.28 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.68 | - | - | - | -0.82 | - | -0.75 | -0.72 | -0.57 | - | -0.63 | -2.11 | -0.46 | - | -0.48 | -5.9 | -6.16 | - | -5.6 | -5.58 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-43.39 | -41.33 | -39.96 | -31.27 | -39.69 | -39.67 | -37.36 | -25.64 | -36.29 | -38.52 | -59.94 | -47.68 | -52.40 | -46.48 | -18.71 | -11.49 | -0.59 | 15.04 | 28.26 | 32.04 | 32.04 | 21.14 | 11.42 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-38.33 | -36.10 | -34.41 | -26.57 | -33.77 | -33.73 | -30.02 | -20.27 | -29.32 | -24.65 | -51.72 | -41.60 | -46.11 | -41.56 | -17.83 | -10.96 | -15.97 | -16.46 | -17.58 | -9.47 | -9.47 | -4.46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-47.84 | -45.80 | -44.11 | -34.00 | -42.59 | -41.73 | -38.62 | -26.02 | -36.70 | -38.79 | -60.11 | -47.76 | -52.56 | -46.68 | -19.01 | -11.89 | 0.25 | 17.19 | 31.85 | 23.17 | 23.17 | 11.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
10.2 | 8.5 | 8.8 | 9.2 | 7.0 | 6.3 | 6.7 | 7.3 | 6.9 | - | 8.8 | 9.1 | 6.7 | 7.5 | 20.0 | 21.9 | 21.9 | 21.9 | 21.9 | 11.0 | 11.0 | 11.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 0.5 | 139.6 | 119.5 | - | 32.0 | 33.6 | 73.2 | - | 74.2 | 15.1 | 3594.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 0.5 | 139.6 | 119.5 | - | 32.0 | 33.6 | 73.2 | - | 74.2 | 15.1 | 3594.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 0.5 | 139.6 | 119.5 | - | 32.0 | 33.6 | 73.2 | - | 74.2 | 15.1 | 3594.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency